BioSpace News Archive

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management and supply chain solutions for health systems, today announced a new partnership with Allegheny Health Network (AHN), to provide central pharmacy dispensing and medication management at the point of care across the network’s 13 hospital locations in western Pennsylvania.

Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that 6-month data from the AVESS first-in-human (FIH) study of the company’s Avess™ AV Fistula drug-coated balloon (DCB) was shared during a morning session at the Vascular Interventional Advances (VIVA) 2020 virtual conference.

Sedor Pharmaceuticals, LLC (Sedor) today announced that the U.S. Food and Drug Administration (FDA) has approved SESQUIENT (fosphenytoin sodium for injection) for the treatment of status epilepticus in adult and pediatric patients. According to Neurocritical Care Society Guidelines, status epilepticus, which is classified as a single epi

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced that the Company’s T cell therapy demonstrates an 86% objective response rate in combination with Merck’s Keytruda® (pembrolizumab) in patients with Program Death Ligand 1 (PD-L1) positive relapsed / refractory diffuse large B-cell lymphoma (r/r DLBCL)

Masimo announced that its Founder, Chairman, and CEO, Joe Kiani, has been honored by the Ibero-American Society of Neonatology at its 17th Annual Congress with the Award for Improvement of Neonatal Health in Latin America.

Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the following November investor conferences. Stifel 2020 Virtual Healthcare Conference Presentation on Wednesday, November 18, 2020, at 4:00 pm EST Canaccord Genuity MedTech & Diagnostics Forum Fireside Chat on Thursday, November 19,

Dr. Atul Gawande—founder and chair of Ariadne Labs, Brigham and Women’s Hospital surgeon, Harvard professor, and best-selling author—was named today as a member of President-elect Biden’s Transition COVID-19 Advisory Board.

Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, today announced Shawn McCormick as its Chief Financial Officer.

Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will participate in the Jefferies Virtual London Healthcare Conference on November 17, 2020 at 12:55 p.m. GMT (7:55 a.m. EST).

Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800, Expected in Fourth Quarter 2020 Phase 1 Safety Study in Humans of TNX-1800 Expected to be Initiated in 2021